Clinical Trial Update: CHT105 for the Treatment of Refractory Lupus Nephritis [NA]

View source ↗

Summary

Clinical trial update for CHT105 evaluating its use in refractory lupus nephritis; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis
• Systemic Lupus Erythematosus

Drugs mentioned

• CHT105

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Systemic Lupus Erythematosus, Lupus Nephritis | NA | Status: NOT_YET_RECRUITING